Li C - Search Results

1

Repurposed drug candidates for antituberculosis therapy.

An Q, Li C, Chen Y, Deng Y, Yang T, Luo Y. An Q, et al. Among authors: li c. Eur J Med Chem. 2020 Apr 15;192:112175. doi: 10.1016/j.ejmech.2020.112175. Epub 2020 Feb 25. Eur J Med Chem. 2020. PMID: 32126450 Review.

2

A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3).

Li C, Chen C, An Q, Yang T, Sang Z, Yang Y, Ju Y, Tong A, Luo Y. Li C, et al. Eur J Med Chem. 2019 Jan 15;162:543-554. doi: 10.1016/j.ejmech.2018.10.067. Epub 2018 Nov 1. Eur J Med Chem. 2019. PMID: 30472602

3

Design, synthesis, and antibacterial evaluation of novel derivatives of NPS-2143 for the treatment of methicillin-resistant S. aureus (MRSA) infection.

Chen Y, Ju Y, Li C, Yang T, Deng Y, Luo Y. Chen Y, et al. Among authors: li c. J Antibiot (Tokyo). 2019 Jul;72(7):545-554. doi: 10.1038/s41429-019-0177-9. Epub 2019 Apr 2. J Antibiot (Tokyo). 2019. PMID: 30940910

4

Discovery of napabucasin derivatives for the treatment of tuberculosis.

Li C, Tang Y, Sang Z, Yang Y, Gao Y, Yang T, Fang C, Zhang T, Luo Y. Li C, et al. Medchemcomm. 2019 Jul 16;10(9):1635-1640. doi: 10.1039/c9md00295b. eCollection 2019 Sep 1. Medchemcomm. 2019. PMID: 31814956 Free PMC article.

5

Scaffold hopping of agomelatine leads to enhanced antidepressant effects by modulation of gut microbiota and host immune responses.

An Q, Li C, Chen Y, Yang Y, Song R, Zhou L, Li J, Tong A, Luo Y. An Q, et al. Among authors: li c, li j. Pharmacol Biochem Behav. 2020 May;192:172910. doi: 10.1016/j.pbb.2020.172910. Epub 2020 Mar 17. Pharmacol Biochem Behav. 2020. PMID: 32194087

6

Repurposing Napabucasin as an Antimicrobial Agent against Oral Streptococcal Biofilms.

Kuang X, Yang T, Zhang C, Peng X, Ju Y, Li C, Zhou X, Luo Y, Xu X. Kuang X, et al. Among authors: li c. Biomed Res Int. 2020 Nov 20;2020:8379526. doi: 10.1155/2020/8379526. eCollection 2020. Biomed Res Int. 2020. PMID: 33274224 Free PMC article.

7

A Novel Small Molecule, LCG-N25, Inhibits Oral Streptococcal Biofilm.

Lyu X, Li C, Zhang J, Wang L, Jiang Q, Shui Y, Chen L, Luo Y, Xu X. Lyu X, et al. Among authors: li c. Front Microbiol. 2021 Mar 29;12:654692. doi: 10.3389/fmicb.2021.654692. eCollection 2021. Front Microbiol. 2021. PMID: 33868212 Free PMC article.

8

Structure-Guided Design of the First Noncovalent Small-Molecule Inhibitor of CRM1.

Lei Y, An Q, Shen XF, Sui M, Li C, Jia D, Luo Y, Sun Q. Lei Y, et al. Among authors: li c. J Med Chem. 2021 May 27;64(10):6596-6607. doi: 10.1021/acs.jmedchem.0c01675. Epub 2021 May 11. J Med Chem. 2021. PMID: 33974430

9

Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment.

Li C, Yang X, Luo Y, Liu H, Zhong X, Zhou X, Zeng T, Tao L, Zhou Y, Gou K, Yang X, Liu X, Chen Q, Zhao Y, Luo Y. Li C, et al. J Med Chem. 2021 Dec 23;64(24):18175-18192. doi: 10.1021/acs.jmedchem.1c01711. Epub 2021 Dec 14. J Med Chem. 2021. PMID: 34905371

10

Corrigendum to "Repurposing Napabucasin as an Antimicrobial Agent against Oral Streptococcal Biofilms".

Kuang X, Yang T, Zhang C, Peng X, Ju Y, Li C, Zhou X, Luo Y, Xu X. Kuang X, et al. Among authors: li c. Biomed Res Int. 2021 Dec 11;2021:9897654. doi: 10.1155/2021/9897654. eCollection 2021. Biomed Res Int. 2021. PMID: 34931170 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89,220 results

Search Page

Filters